Heather Joanne Baer, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Overweight | 8 | 2023 | 2421 | 1.030 |
Why?
|
| Body Size | 5 | 2012 | 462 | 1.030 |
Why?
|
| Obesity | 10 | 2023 | 12915 | 0.710 |
Why?
|
| Breast Diseases | 9 | 2014 | 443 | 0.700 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2012 | 415 | 0.690 |
Why?
|
| Primary Health Care | 7 | 2024 | 4649 | 0.630 |
Why?
|
| Problem-Based Learning | 1 | 2022 | 352 | 0.610 |
Why?
|
| Education, Distance | 1 | 2022 | 259 | 0.610 |
Why?
|
| Adiposity | 6 | 2022 | 1851 | 0.540 |
Why?
|
| Electronic Health Records | 6 | 2021 | 4763 | 0.470 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2012 | 1920 | 0.460 |
Why?
|
| Body Mass Index | 16 | 2023 | 12901 | 0.440 |
Why?
|
| Breast Neoplasms | 19 | 2022 | 21065 | 0.420 |
Why?
|
| Education, Medical, Graduate | 2 | 2022 | 2359 | 0.410 |
Why?
|
| Premenopause | 5 | 2007 | 1039 | 0.400 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2012 | 125 | 0.400 |
Why?
|
| Patient Preference | 1 | 2019 | 921 | 0.390 |
Why?
|
| Weight Loss | 1 | 2020 | 2683 | 0.320 |
Why?
|
| Students, Medical | 1 | 2022 | 1926 | 0.310 |
Why?
|
| Physicians, Primary Care | 1 | 2015 | 624 | 0.310 |
Why?
|
| Breast | 5 | 2009 | 1980 | 0.300 |
Why?
|
| Sex Factors | 1 | 2022 | 10530 | 0.300 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2009 | 487 | 0.300 |
Why?
|
| Documentation | 1 | 2013 | 892 | 0.280 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2007 | 240 | 0.270 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2007 | 701 | 0.270 |
Why?
|
| Attitude of Health Personnel | 2 | 2021 | 3870 | 0.270 |
Why?
|
| Adult | 48 | 2023 | 219847 | 0.260 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2005 | 103 | 0.250 |
Why?
|
| Internet | 2 | 2019 | 3074 | 0.250 |
Why?
|
| Young Adult | 17 | 2023 | 58673 | 0.240 |
Why?
|
| Health Behavior | 3 | 2011 | 2621 | 0.240 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2024 | 1162 | 0.220 |
Why?
|
| Nurses | 5 | 2010 | 2468 | 0.220 |
Why?
|
| Life Style | 3 | 2013 | 3888 | 0.220 |
Why?
|
| Female | 57 | 2024 | 391011 | 0.220 |
Why?
|
| Indians, North American | 2 | 2006 | 355 | 0.210 |
Why?
|
| Health Surveys | 4 | 2011 | 4061 | 0.210 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2005 | 385 | 0.200 |
Why?
|
| Patient-Centered Care | 2 | 2023 | 1416 | 0.200 |
Why?
|
| Middle Aged | 37 | 2024 | 220175 | 0.190 |
Why?
|
| Hypertension | 5 | 2024 | 8595 | 0.190 |
Why?
|
| Physician-Patient Relations | 1 | 2015 | 3242 | 0.190 |
Why?
|
| Adolescent | 25 | 2021 | 87747 | 0.190 |
Why?
|
| Birth Weight | 4 | 2012 | 2094 | 0.190 |
Why?
|
| Pregnant Women | 1 | 2005 | 563 | 0.180 |
Why?
|
| Osmolar Concentration | 1 | 2021 | 662 | 0.180 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2024 | 2296 | 0.170 |
Why?
|
| Body Height | 1 | 2006 | 1570 | 0.170 |
Why?
|
| Cause of Death | 1 | 2010 | 3723 | 0.170 |
Why?
|
| Urine | 1 | 2021 | 363 | 0.170 |
Why?
|
| Condylomata Acuminata | 1 | 2000 | 75 | 0.170 |
Why?
|
| Men | 1 | 2000 | 64 | 0.170 |
Why?
|
| Humans | 65 | 2024 | 760261 | 0.170 |
Why?
|
| Risk Factors | 26 | 2016 | 74269 | 0.170 |
Why?
|
| Competency-Based Education | 1 | 2021 | 218 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 12281 | 0.160 |
Why?
|
| Eating | 1 | 2005 | 1538 | 0.160 |
Why?
|
| Women | 1 | 2000 | 224 | 0.150 |
Why?
|
| Diet | 5 | 2014 | 8008 | 0.150 |
Why?
|
| Medical History Taking | 2 | 2013 | 773 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2011 | 3967 | 0.150 |
Why?
|
| Accreditation | 1 | 2021 | 477 | 0.150 |
Why?
|
| Albuminuria | 1 | 2021 | 659 | 0.150 |
Why?
|
| Genetic Testing | 1 | 2010 | 3530 | 0.140 |
Why?
|
| Massachusetts | 3 | 2015 | 8805 | 0.140 |
Why?
|
| Kidney Transplantation | 3 | 2017 | 4215 | 0.140 |
Why?
|
| Aged | 18 | 2024 | 168995 | 0.140 |
Why?
|
| Antihypertensive Agents | 2 | 2024 | 2063 | 0.140 |
Why?
|
| Proportional Hazards Models | 8 | 2017 | 12532 | 0.140 |
Why?
|
| Psychometrics | 1 | 2005 | 3049 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2010 | 9283 | 0.130 |
Why?
|
| Fracture Fixation | 1 | 2018 | 366 | 0.130 |
Why?
|
| Ovarian Neoplasms | 2 | 2009 | 4875 | 0.120 |
Why?
|
| United States | 17 | 2021 | 72363 | 0.120 |
Why?
|
| Adolescent Behavior | 1 | 2003 | 1183 | 0.120 |
Why?
|
| Hemodialysis, Home | 1 | 2014 | 18 | 0.120 |
Why?
|
| Adipose Tissue | 3 | 2016 | 3293 | 0.120 |
Why?
|
| Dietary Fiber | 3 | 2010 | 760 | 0.120 |
Why?
|
| Universities | 1 | 2000 | 983 | 0.120 |
Why?
|
| Esophageal Neoplasms | 1 | 2005 | 1651 | 0.120 |
Why?
|
| Mammary Glands, Human | 1 | 2015 | 204 | 0.110 |
Why?
|
| Needs Assessment | 1 | 2000 | 1137 | 0.110 |
Why?
|
| Focus Groups | 1 | 2019 | 1372 | 0.110 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2016 | 406 | 0.110 |
Why?
|
| Risk | 4 | 2012 | 9629 | 0.110 |
Why?
|
| Health Education | 1 | 2000 | 1049 | 0.110 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 2178 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 15766 | 0.110 |
Why?
|
| Neoplasms | 3 | 2013 | 22066 | 0.100 |
Why?
|
| Mortality | 2 | 2016 | 2916 | 0.100 |
Why?
|
| Aging | 1 | 2011 | 8641 | 0.100 |
Why?
|
| Male | 21 | 2024 | 359413 | 0.100 |
Why?
|
| Sternotomy | 1 | 2013 | 127 | 0.100 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2017 | 623 | 0.100 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 1381 | 0.100 |
Why?
|
| Child | 13 | 2022 | 79758 | 0.100 |
Why?
|
| Follow-Up Studies | 8 | 2022 | 39254 | 0.100 |
Why?
|
| Steroids | 1 | 2017 | 928 | 0.100 |
Why?
|
| Anthropometry | 2 | 2007 | 1348 | 0.100 |
Why?
|
| Research | 1 | 2000 | 1973 | 0.090 |
Why?
|
| Risk Assessment | 6 | 2018 | 24086 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 2753 | 0.090 |
Why?
|
| Molecular Typing | 1 | 2011 | 116 | 0.090 |
Why?
|
| Attitude to Health | 1 | 2000 | 2028 | 0.090 |
Why?
|
| Age Factors | 5 | 2016 | 18415 | 0.090 |
Why?
|
| Minority Health | 1 | 2011 | 80 | 0.090 |
Why?
|
| Students | 1 | 2000 | 1722 | 0.090 |
Why?
|
| Child, Preschool | 8 | 2012 | 42034 | 0.090 |
Why?
|
| Dietary Fats | 3 | 2014 | 1992 | 0.080 |
Why?
|
| Hip Fractures | 1 | 2018 | 989 | 0.080 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2008 | 1094 | 0.080 |
Why?
|
| Body Weights and Measures | 1 | 2009 | 208 | 0.080 |
Why?
|
| Tracheostomy | 1 | 2013 | 425 | 0.080 |
Why?
|
| Qualitative Research | 1 | 2019 | 2958 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8551 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 3451 | 0.080 |
Why?
|
| Critical Illness | 1 | 2021 | 2709 | 0.070 |
Why?
|
| Nuts | 1 | 2010 | 263 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2018 | 1570 | 0.070 |
Why?
|
| Cohort Studies | 12 | 2017 | 41317 | 0.070 |
Why?
|
| Consumer Health Information | 1 | 2010 | 209 | 0.070 |
Why?
|
| Incidence | 6 | 2014 | 21378 | 0.070 |
Why?
|
| Body Weight | 4 | 2010 | 4613 | 0.070 |
Why?
|
| Prospective Studies | 9 | 2015 | 54263 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 2016 | 1802 | 0.070 |
Why?
|
| Time Factors | 5 | 2020 | 40133 | 0.070 |
Why?
|
| Case-Control Studies | 5 | 2012 | 22041 | 0.070 |
Why?
|
| Receptors, Estrogen | 3 | 2011 | 2202 | 0.070 |
Why?
|
| Biopsy | 5 | 2009 | 6775 | 0.070 |
Why?
|
| Graft Survival | 1 | 2016 | 3793 | 0.070 |
Why?
|
| Kidney | 1 | 2021 | 7072 | 0.070 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 25928 | 0.060 |
Why?
|
| Retrospective Studies | 11 | 2021 | 80301 | 0.060 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2006 | 159 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 2002 | 0.060 |
Why?
|
| Preventive Health Services | 1 | 2010 | 571 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2021 | 4786 | 0.060 |
Why?
|
| Exercise | 1 | 2021 | 5783 | 0.060 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2007 | 546 | 0.060 |
Why?
|
| Pathology | 1 | 2008 | 270 | 0.060 |
Why?
|
| Prolactin | 1 | 2006 | 621 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2932 | 0.060 |
Why?
|
| Poverty | 2 | 2006 | 2695 | 0.060 |
Why?
|
| Mammography | 2 | 2022 | 2452 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2016 | 2469 | 0.060 |
Why?
|
| Nutrition Surveys | 2 | 2021 | 1727 | 0.060 |
Why?
|
| Laboratories | 1 | 2008 | 461 | 0.060 |
Why?
|
| Vitamin D | 2 | 2021 | 3293 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 4168 | 0.060 |
Why?
|
| Tissue Array Analysis | 3 | 2011 | 551 | 0.060 |
Why?
|
| Surgical Wound Infection | 1 | 2013 | 1529 | 0.060 |
Why?
|
| Graft Rejection | 1 | 2017 | 4423 | 0.060 |
Why?
|
| Self-Assessment | 1 | 2005 | 393 | 0.060 |
Why?
|
| Nutrition Assessment | 1 | 2006 | 725 | 0.060 |
Why?
|
| Odds Ratio | 5 | 2011 | 9712 | 0.050 |
Why?
|
| Menstruation | 1 | 2005 | 307 | 0.050 |
Why?
|
| Medical Records | 1 | 2008 | 1407 | 0.050 |
Why?
|
| Mass Screening | 2 | 2010 | 5422 | 0.050 |
Why?
|
| Precancerous Conditions | 1 | 2009 | 978 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2013 | 5201 | 0.050 |
Why?
|
| Vegetables | 2 | 2006 | 1198 | 0.050 |
Why?
|
| Delivery of Health Care | 2 | 2010 | 5324 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2010 | 1132 | 0.050 |
Why?
|
| Endometriosis | 1 | 2010 | 871 | 0.050 |
Why?
|
| Abbreviated Injury Scale | 1 | 2021 | 49 | 0.050 |
Why?
|
| Blood Pressure | 2 | 2021 | 8523 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2015 | 5993 | 0.050 |
Why?
|
| Communication | 1 | 2015 | 3846 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2021 | 5867 | 0.040 |
Why?
|
| Treatment Outcome | 5 | 2020 | 64947 | 0.040 |
Why?
|
| Family | 1 | 2010 | 3189 | 0.040 |
Why?
|
| Carcinoma in Situ | 1 | 2005 | 796 | 0.040 |
Why?
|
| Research Design | 1 | 2015 | 6181 | 0.040 |
Why?
|
| Calcium | 1 | 2012 | 5726 | 0.040 |
Why?
|
| Hyperplasia | 3 | 2007 | 1158 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 3215 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2013 | 4361 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2013 | 17766 | 0.040 |
Why?
|
| Age of Onset | 1 | 2005 | 3302 | 0.040 |
Why?
|
| Epoprostenol | 1 | 2018 | 248 | 0.040 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 3618 | 0.040 |
Why?
|
| Injury Severity Score | 1 | 2021 | 1035 | 0.040 |
Why?
|
| Waist-Hip Ratio | 2 | 2009 | 516 | 0.040 |
Why?
|
| New England | 1 | 2000 | 1045 | 0.030 |
Why?
|
| Austria | 1 | 2017 | 206 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 1723 | 0.030 |
Why?
|
| Prevalence | 3 | 2021 | 15687 | 0.030 |
Why?
|
| Socioeconomic Factors | 2 | 2011 | 7803 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2011 | 9388 | 0.030 |
Why?
|
| Pemphigoid, Benign Mucous Membrane | 1 | 1996 | 115 | 0.030 |
Why?
|
| Vitamins | 1 | 2004 | 1635 | 0.030 |
Why?
|
| Conjunctival Diseases | 1 | 1996 | 110 | 0.030 |
Why?
|
| Alcohol Drinking | 2 | 2006 | 4012 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 15273 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2018 | 15680 | 0.030 |
Why?
|
| Hospital Mortality | 2 | 2021 | 5420 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2021 | 934 | 0.030 |
Why?
|
| Receptors, Progesterone | 2 | 2011 | 1122 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2016 | 555 | 0.030 |
Why?
|
| Prognosis | 2 | 2011 | 29636 | 0.030 |
Why?
|
| Smoking | 1 | 2010 | 9070 | 0.030 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2010 | 1191 | 0.030 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 12156 | 0.030 |
Why?
|
| Child Development | 1 | 2005 | 2280 | 0.030 |
Why?
|
| Conjunctiva | 1 | 1996 | 479 | 0.030 |
Why?
|
| Pregnancy | 4 | 2010 | 29725 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2000 | 1249 | 0.030 |
Why?
|
| Ontario | 1 | 2013 | 405 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2016 | 754 | 0.020 |
Why?
|
| Keratin-6 | 1 | 2011 | 18 | 0.020 |
Why?
|
| Keratin-5 | 1 | 2011 | 45 | 0.020 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2013 | 217 | 0.020 |
Why?
|
| Micronutrients | 1 | 2014 | 380 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2004 | 3389 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2010 | 6361 | 0.020 |
Why?
|
| Menopause | 2 | 2009 | 1640 | 0.020 |
Why?
|
| Ohio | 1 | 2010 | 333 | 0.020 |
Why?
|
| Living Donors | 1 | 2014 | 636 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2011 | 389 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14656 | 0.020 |
Why?
|
| Medical Audit | 1 | 2010 | 453 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2010 | 524 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 2013 | 841 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3804 | 0.020 |
Why?
|
| Canada | 1 | 2014 | 2128 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 2 | 2008 | 3618 | 0.020 |
Why?
|
| Collagen | 1 | 1996 | 2635 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 4814 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2014 | 2646 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2000 | 2018 | 0.020 |
Why?
|
| Mass Media | 1 | 2010 | 300 | 0.020 |
Why?
|
| North Dakota | 1 | 2006 | 14 | 0.020 |
Why?
|
| Length of Stay | 1 | 2021 | 6472 | 0.020 |
Why?
|
| Keratins | 1 | 2008 | 497 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6499 | 0.020 |
Why?
|
| Women's Health | 2 | 2008 | 2057 | 0.020 |
Why?
|
| Thinness | 1 | 2010 | 491 | 0.020 |
Why?
|
| Medically Uninsured | 1 | 2011 | 843 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6545 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2009 | 922 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 2893 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 15740 | 0.020 |
Why?
|
| Patient Admission | 1 | 2013 | 1384 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2011 | 926 | 0.020 |
Why?
|
| Nutritional Requirements | 1 | 2006 | 275 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 2013 | 1328 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 10340 | 0.010 |
Why?
|
| Health Status | 1 | 2018 | 4081 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2013 | 1228 | 0.010 |
Why?
|
| Minority Groups | 1 | 2011 | 1199 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 1395 | 0.010 |
Why?
|
| Logistic Models | 2 | 2010 | 13311 | 0.010 |
Why?
|
| Parity | 1 | 2006 | 925 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2010 | 2434 | 0.010 |
Why?
|
| Reoperation | 1 | 2013 | 4292 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2013 | 2623 | 0.010 |
Why?
|
| Family Health | 1 | 2006 | 1258 | 0.010 |
Why?
|
| Fruit | 1 | 2006 | 1162 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2011 | 2544 | 0.010 |
Why?
|
| Critical Care | 1 | 2013 | 2699 | 0.010 |
Why?
|
| Diet Surveys | 1 | 2004 | 1161 | 0.010 |
Why?
|
| Lipids | 1 | 2010 | 3336 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 36247 | 0.010 |
Why?
|
| Health Promotion | 1 | 2010 | 2208 | 0.010 |
Why?
|
| Motor Activity | 1 | 2007 | 2687 | 0.010 |
Why?
|
| Weight Gain | 1 | 2007 | 2347 | 0.010 |
Why?
|
| Antioxidants | 1 | 2004 | 1668 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2010 | 6375 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2005 | 2909 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1996 | 426 | 0.010 |
Why?
|
| Pediatrics | 1 | 2010 | 3587 | 0.010 |
Why?
|
| Liver | 1 | 2010 | 7512 | 0.010 |
Why?
|
| Hospitalization | 1 | 2014 | 10761 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 11064 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 5884 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2007 | 5073 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 58947 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2011 | 7809 | 0.010 |
Why?
|
| Corneal Diseases | 1 | 1996 | 536 | 0.010 |
Why?
|
| Phenotype | 1 | 2008 | 16543 | 0.010 |
Why?
|